Visual cortex excitability in migraine with and without aura WM Mulleners, EP Chronicle, JE Palmer, PJ Koehler, JW Vredeveld Headache: The Journal of Head and Face Pain 41 (6), 565-572, 2001 | 257 | 2001 |
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised … WM Mulleners, BK Kim, MJA Láinez, M Lanteri-Minet, P Pozo-Rosich, ... The Lancet Neurology 19 (10), 814-825, 2020 | 239 | 2020 |
Anticonvulsant drugs for migraine prophylaxis EP Chronicle, WM Mulleners Cochrane Database of Systematic Reviews, 2004 | 223 | 2004 |
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults M Linde, WM Mulleners, EP Chronicle, DC McCrory, ... Cochrane Database of Systematic Reviews 2016 (7), 1996 | 200 | 1996 |
Topiramate for the prophylaxis of episodic migraine in adults M Linde, WM Mulleners, EP Chronicle, DC McCrory, ... Cochrane Database of Systematic Reviews 2016 (5), 1996 | 196 | 1996 |
Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients JE Palmer, EP Chronicle, P Rolan, WM Mulleners Cephalalgia 20 (6), 525-532, 2000 | 162 | 2000 |
Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands M Brouwer, A Huss, M van der Mark, PCG Nijssen, WM Mulleners, ... Environment international 107, 100-110, 2017 | 160 | 2017 |
Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT) MA van der Marck, M Munneke, W Mulleners, EM Hoogerwaard, GF Borm, ... The Lancet Neurology 12 (10), 947-956, 2013 | 147 | 2013 |
Anticonvulsants in migraine prophylaxis: a Cochrane review WM Mulleners, EP Chronicle Cephalalgia 28 (6), 585-597, 2008 | 146 | 2008 |
Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness SK Aurora, P Barrodale, EP Chronicle, WM Mulleners Headache: The Journal of Head and Face Pain 45 (5), 546-552, 2005 | 145 | 2005 |
Suppression of perception in migraine: evidence for reduced inhibition in the visual cortex WM Mulleners, EP Chronicle, JE Palmer, PJ Koehler, JW Vredeveld Neurology 56 (2), 178-183, 2001 | 143 | 2001 |
Visual system dysfunction in migraine: a review of clinical and psychophysical findings EP Chronicle, WM Mulleners Cephalalgia 16 (8), 525-535, 1996 | 140 | 1996 |
Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS WM Mulleners, EP Chronicle, JW Vredeveld, PJ Koehler European journal of neurology 9 (1), 35-40, 2002 | 126 | 2002 |
Noncompliance may render migraine prophylaxis useless, but once‐daily regimens are better WM Mulleners, TE Whitmarsh, TJ Steiner Cephalalgia 18 (1), 52-56, 1998 | 114 | 1998 |
Self‐reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately WM Mulleners, SK Aurora, EP Chronicle, R Stewart, S Gopal, PJ Koehler Headache: The Journal of Head and Face Pain 41 (1), 31-39, 2001 | 111 | 2001 |
The ParkinsonNet concept: development, implementation and initial experience MJ Nijkrake, SHJ Keus, S Overeem, RAB Oostendorp, TPMV Vlieland, ... Movement Disorders 25 (7), 823-829, 2010 | 109 | 2010 |
Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults M Linde, WM Mulleners, EP Chronicle, DC McCrory, ... Cochrane Database of Systematic Reviews 2016 (5), 1996 | 108 | 1996 |
Might migraine damage the brain? E Chronicle, W Mulleners Cephalalgia 14 (6), 415-418, 1994 | 108 | 1994 |
Allied health care in Parkinson's disease: referral, consultation, and professional expertise MJ Nijkrake, SHJ Keus, RAB Oostendorp, S Overeem, W Mulleners, ... Movement disorders: official journal of the Movement Disorder Society 24 (2 …, 2009 | 106 | 2009 |
Antiepileptics in migraine prophylaxis: an updated Cochrane review WM Mulleners, DC McCrory, M Linde Cephalalgia 35 (1), 51-62, 2015 | 104 | 2015 |